| Ytd | -3.92% | |
| 1y | -11.50% |
| Open | 34.71 | Prev Close | 34.44 | Low | 33.64 | High | 34.85 | Mkt Cap | 3.94B |
| Vol | 0.00 | Avg Vol | 2.29M | EPS | -4.14 | P/E | -8.16 | Forward P/E | -7.90 |
| Beta | 0.69 | Short Ratio | 7.98 | Inst. Own | 64.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 34.32 | 200-d Avg | 33.79 | 1yr Est | 92.92 |
Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeut
Dimensional Fund Advisors LP boosted its stake in Viking Therapeutics, Inc. (NASDAQ: VKTX) by 18.0%
Viking Therapeutics (VKTX) maintains a Hold rating as competitive pressures intensify in the GLP-1 o
In a slow news month for the company, investors focused on the cost of its phase 3 trials rather tha
Viking Therapeutics beats second-quarter loss estimates as it advances late-stage obesity studies de
Viking Therapeutics, Inc. (VKTX) Q2 2026 Earnings Call Transcript
Viking Therapeutics NASDAQ: VKTX reported a wider second-quarter loss as the company increased spend
Conference call scheduled for 4:30 p.m. ET today -- Phase 3 VANQUISH 1 & 2 Trials for Subcutaneous V
Biotech is setting up as one of the more interesting risk-on trades heading into the back half of 20
Viking Therapeutics has a promising pipeline candidate in late-stage studies. Positive results from
Biotech earnings take center stage as Viking, Biogen, Bristol Myers, Regeneron and AbbVie prepare to
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
Viking Therapeutics, Inc. (VKTX) reached $35.39 at the closing of the latest trading day, reflecting
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Experienced Executive Brings Over Two Decades of Leadership Across Healthcare, Digital Health and Co
Conference Call Scheduled for Wednesday, July 29, at 4:30 p.m. Eastern Time SAN DIEGO, July 22, 202
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
Viking Therapeutics just launched its next-gen weight loss program. Novo Nordisk and Eli Lilly are a
The key trial results for VK2735 are still years away. There are some useful indicative results comi
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $37.08, representing a +1.95
VKTX's Q2 report could hinge on VK2735 pipeline updates as investors await progress on obesity studi
A deepening chipmaker slide pulls all major U.S. indexes lower Tuesday while oil climbs on a Strait
A global semiconductor sell-off hammered the Nasdaq on Tuesday, but a rotation into defensives and s
U.S. stocks sank Monday as an Iranian drone attack on a UAE petroleum site sent Brent above $114, go
Wall Street opened the week under heavy pressure as risk sentiment deteriorated on AI-related credit
Investors are anticipating reports from Robinhood, Pinterest, Rivian and more. Here's a look at
U.S. stocks rallied near record territory on Thursday as blowout earnings from major Wall Street fir
Zoom Communications is a good company, Cramer says. Still, he advises, "take a pass." Plus:
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quart
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earn
Companies Reporting Before The Bell • GSK (NYSE:GSK) is estimated to report quarterly earnings at $
Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly ea
Gainers
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its four
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co